Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors

Author： Danesi Romano   Altavilla Giuseppe   Giovannetti Elisa   Rosell Raffael  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.1, 2009-01, pp. : 69-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

By  

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 61-66

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of Non-Small Cell Lung Cancer

By  

Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. : 228-234

Bentham Science Publishers

Access to resources Recommend Favorite

Gemcitabine in non-small cell lung cancer

By Cappuzzo Federico   Crinò Lucio  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 745-753

Informa Healthcare

Access to resources Recommend Favorite

Quality-of-Life Assessment in Phase III Clinical Trials of Gemcitabine in Non-Small-Cell Lung Cancer

By Reynolds Jonathan K.  

Drugs & Aging, Vol. 25, Iss. 11, 2008-01 ,pp. : 893-911

Adis International

Access to resources Recommend Favorite

Erlotinib Resistance is Altered after Gemcitabine Chemotherapy for Recurrent Non-Small-Cell Lung Cancer

By Wang Yongzheng  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 279-283

Adis International

Access to resources Recommend Favorite